Embracing the 80-80 Rule to Ignite Growth in the Biopharmaceutical Industry.
.PUBLICATION, DISTRIBUTION, ETC
Place of Publication, Distribution, etc.
Milton :
Name of Publisher, Distributor, etc.
Productivity Press,
Date of Publication, Distribution, etc.
2018.
PHYSICAL DESCRIPTION
Specific Material Designation and Extent of Item
1 online resource (229 pages)
INTERNAL BIBLIOGRAPHIES/INDEXES NOTE
Text of Note
Includes bibliographical references and index.
CONTENTS NOTE
Text of Note
Cover; Half Title; Title Page; Copyright Page; Contents; Reviews; Setting the Context; Foreword; Preface; Acknowledgments; The 80-80 Rule; Section I: Redefining Innovation; 1. Rise of a Unicorn Industry; Unintended Consequences of Disconnected Choices; The Western Biopharmaceutical Industry Takes Shape; The Golden Era; A "Unicorn Industry" Is in Place; A Perspective on Global Differences in Reimbursement of Biopharmaceuticals; Endnotes; 2. The Unicorn Industry Loses Its Wings; Limited White Spaces for Traditional Product-Focused Innovation; Therapies versus Cures.
Text of Note
5. Next-Generation Unicorn IndustryEndnotes; Section II: Igniting Growth; 6. Applying "The 80-80 Rule"; 7. Setting Up for Success; Leadership Foresight and Courage to Invest; A New Breed of Leaders; Teaming the Right Talent; Reflections on the Experiment in Challenging the Status Quo; Endnote; 8. Finding White Spaces; Embrace the Need, Money Will Follow; Outside In First, Inside Out Next; Endnotes; 9. Developing New Ventures; Design for the End User, but Consider the Ecosystem; Keep It Modular; Keep It Simple; 10. Becoming Adept at Partnering.
Text of Note
Outcome and Value versus Safety and EfficacyTransition from Old to New Technology; Commoditization; Consumerism; New Disruptors; Evolution of the Regulatory Framework as a Source of Disruption; An Industry Perspective; The Future?; Endnotes; 3. An Experiment in Challenging the Status Quo; Challenging the Status Quo; Innovation Is Not a Choice; Endnotes; 4. Innovation Redefined; Redefining Innovation; Drive the Core, but Know It Is a Short-Term Game; Invest in Adjacent; It Is Easier to Execute; Experiment with Breakthrough to Define New Futures; Beyond Healthcare; Endnotes.
Text of Note
Partnerships That Span Development and CommercializationMaking Partnerships Work; 11. Afterword; Authors; Index.
0
8
8
8
ACQUISITION INFORMATION NOTE
Source for Acquisition/Subscription Address
Ingram Content Group
Stock Number
9780429015922
OTHER EDITION IN ANOTHER MEDIUM
Title
Redefining Innovation : Embracing the 80-80 Rule to Ignite Growth in the Biopharmaceutical Industry.